CSIMarket
 


Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 
 

CASI's Revenue Growth by Quarter and Year

Casi Pharmaceuticals Inc 's Revenue results by quarter and year




CASI Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 43.11 9.16 4.82 1.46
III Quarter September 0.00 8.11 4.24 2.79
II Quarter June 0.00 7.16 2.67 -0.80
I Quarter March 0.00 5.74 3.41 -0.12
FY   43.11 30.17 15.14 3.33



CASI Revenue fourth quarter 2022 Y/Y Growth Comment
Casi Pharmaceuticals inc achieved in the fourth quarter 2022, above Company average Revenue surge of 370.6% year on year, to $ 43.11 millions.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 25 other companies have achieved higher Revenue growth. While Casi Pharmaceuticals Inc ' s Revenue doubling of 370.6% ranks overall at the positon no. 113 in the fourth quarter 2022.




CASI Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December 370.6 % 90.04 % 230.14 % -
III Quarter September - 91.27 % 51.97 % -
II Quarter June - 168.16 % - -
I Quarter March - 68.33 % - -
FY   42.88 % 99.27 % 354.65 % -

Financial Statements
Casi Pharmaceuticals Inc 's fourth quarter 2022 Revenue $ 43.11 millions CASI's Income Statement
Casi Pharmaceuticals Inc 's fourth quarter 2021 Revenue $ 9.16 millions Quarterly CASI's Income Statement
New: More CASI's historic Revenue Growth >>


CASI Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 12.95 % 13.68 % -47.67 %
III Quarter September - 13.27 % 58.8 % -
II Quarter June - 24.74 % -21.7 % -
I Quarter March - 19.09 % 133.56 % -
FY (Year on Year)   42.88 % 99.27 % 354.65 % -




Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #26
Healthcare Sector #44
Overall #113

Revenue Y/Y Growth Statistics
High Average Low
370.7 % 77.01 % -100 %
(Dec 31 2022)   0
Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #26
Healthcare Sector #44
Overall #113
Revenue Y/Y Growth Statistics
High Average Low
370.7 % 77.01 % -100 %
(Dec 31 2022)   0

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Casi Pharmaceuticals Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CASI's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CASI's IV. Quarter Q/Q Revenue Comment


Casi Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 37.01 $ 34.91 $ 33.49 $ 30.17 $ 25.83
Y / Y Revenue Growth (TTM) 43.26 % 58.93 % 91.71 % 99.25 % 119.24 %
Year on Year Revenue Growth Overall Ranking # 181 # 606 # 539 # 403 # 229
Seqeuential Revenue Change (TTM) 6.02 % 4.21 % 11.02 % 16.79 % 17.62 %
Seq. Revenue Growth (TTM) Overall Ranking # 1404 # 933 # 1395 # 662 # 1660




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Casi Pharmaceuticals Inc 's cumulative twelve months Revenue were $ 37 millions, company would post below average annual Revenue growth of 17.62% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Casi Pharmaceuticals Inc 's Revenue growth from the 0% growth in Jun 30 2022.

In the Healthcare sector 45 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 181, from total ranking in previous quarter at 606.

Revenue TTM Q/Q Growth Statistics
High Average Low
547.46 %
175.77 %
43.26 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 42
Healthcare Sector # 46
Overall # 181

Revenue TTM Y/Y Growth Statistics
High Average Low
547.46 %
175.77 %
43.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 211
S&P 500 # 1404
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2022 period, Casi Pharmaceuticals Inc 's cumulative twelve months Revenue were $ 37 millions, company would post below average annual Revenue growth of 43.26% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Casi Pharmaceuticals Inc 's Revenue growth from the 0% growth in Jun 30 2022.

In the Healthcare sector 45 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 181, from total ranking in previous quarter at 606.

Revenue TTM Q/Q Growth Statistics
High Average Low
547.46 %
175.77 %
43.26 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 42
Healthcare Sector # 46
Overall # 181

Revenue TTM Y/Y Growth Statistics
High Average Low
547.46 %
175.77 %
43.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 211
S&P 500 # 1404




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CASI's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CASI's Competitors
Revenue Growth for Casi Pharmaceuticals Inc 's Suppliers
Revenue Growth for CASI's Customers

You may also want to know
CASI's Annual Growth Rates CASI's Profitability Ratios CASI's Asset Turnover Ratio CASI's Dividend Growth
CASI's Roe CASI's Valuation Ratios CASI's Financial Strength Ratios CASI's Dividend Payout Ratio
CASI's Roa CASI's Inventory Turnover Ratio CASI's Growth Rates CASI's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2022
Anaptysbio Inc 573.39%$ 573.393 millions
Ascendis Pharma A557.93%$ 557.933 millions
Nano x Imaging Ltd557.82%$ 557.822 millions
Adaptimmune Therapeutics Plc530.86%$ 530.857 millions
Adc Therapeutics Sa518.89%$ 518.887 millions
Biocorrx Inc 508.83%$ 508.830 millions
Foghorn Therapeutics Inc 486.82%$ 486.816 millions
Recursion Pharmaceuticals Inc 439.91%$ 439.913 millions
Macrogenics Inc 416.71%$ 416.710 millions
Aclaris Therapeutics Inc 416.52%$ 416.522 millions
Celldex Therapeutics inc 384.38%$ 384.384 millions
Marinus Pharmaceuticals Inc 371.18%$ 371.184 millions
Casi Pharmaceuticals inc 370.70%$ 370.703 millions
Aadi Bioscience Inc 366.70%$ 366.696 millions
Carisma Therapeutics Inc 356.41%$ 356.413 millions
Palatin Technologies Inc 310.57%$ 310.566 millions
Avalo Therapeutics Inc 307.27%$ 307.273 millions
Sintx Technologies Inc 297.58%$ 297.576 millions
Pulmatrix Inc 274.56%$ 274.561 millions
Vbi Vaccines Inc261.73%$ 261.728 millions
Intra cellular Therapies Inc 242.29%$ 242.290 millions
Neuroone Medical Technologies Corporation239.51%$ 239.513 millions
Kiniksa Pharmaceuticals ltd 230.14%$ 230.136 millions
Y mabs Therapeutics inc 227.64%$ 227.641 millions
Transmedics Group Inc 224.52%$ 224.524 millions
Mirati Therapeutics Inc 212.37%$ 212.375 millions
Mannkind Corporation188.13%$ 188.126 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com